Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Dabigatran Etexilate in Renal Impairment
NCT02182024Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of dabigatran in thromboembolism (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity, Maximum plasma concentration and 5 more. Started Apr 2005; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02182024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182024.